{"title":"Brief Provider Education is Associated with Decreased ED Visits by Super-utilizers.","authors":"Kjerstin Hensley, Benjamin Aaker","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Millions of adult visits to emergency departments (EDs) each year are opioid-related, and those who visit with chronic pain are more likely to be super-utilizers (SUs) of the ED. Although SUs comprise 5% of the general population, they account for 50% of health care expenditure.</p><p><strong>Objective: </strong>Determine whether brief provider opioid education results in decreased number of SUs and total ED visits by SUs.</p><p><strong>Methods: </strong>The American Academy of Emergency Medicine's ED Opioid Prescribing Guidelines were presented to five EDs (estimated total 70,000 ED annual patient volume). ICD-10 codes from visits one year before and after the education were evaluated for painful diagnoses and identified patients who fit the definition of SU. Statistical analysis was performed on the data using McNemar's test and Z-scores.</p><p><strong>Results: </strong>A statistically significant decrease (p=0.0006) in patients who visited the ED more than once after the education compared to prior to the education (n=304) was found. A statistically significant decrease (p=0.0017) in total number of visits after the education (n=268) by SU patients was found. No statistically significant change in visits made by non-SU patients (p=1.9983), nor average number of visits made by SUs (p=0.2320) was found.</p><p><strong>Conclusion: </strong>Providing opioid education to ED providers was associated with a significant reduction in number of SUs visiting the ED and number of visits made by SUs. Based on average costs of ED visits by SUs, this decrease in visits can be correlated to an estimated savings of over $1 million across five EDs.</p>","PeriodicalId":39219,"journal":{"name":"South Dakota medicine : the journal of the South Dakota State Medical Association","volume":"77 3","pages":"108-111"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Dakota medicine : the journal of the South Dakota State Medical Association","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Millions of adult visits to emergency departments (EDs) each year are opioid-related, and those who visit with chronic pain are more likely to be super-utilizers (SUs) of the ED. Although SUs comprise 5% of the general population, they account for 50% of health care expenditure.
Objective: Determine whether brief provider opioid education results in decreased number of SUs and total ED visits by SUs.
Methods: The American Academy of Emergency Medicine's ED Opioid Prescribing Guidelines were presented to five EDs (estimated total 70,000 ED annual patient volume). ICD-10 codes from visits one year before and after the education were evaluated for painful diagnoses and identified patients who fit the definition of SU. Statistical analysis was performed on the data using McNemar's test and Z-scores.
Results: A statistically significant decrease (p=0.0006) in patients who visited the ED more than once after the education compared to prior to the education (n=304) was found. A statistically significant decrease (p=0.0017) in total number of visits after the education (n=268) by SU patients was found. No statistically significant change in visits made by non-SU patients (p=1.9983), nor average number of visits made by SUs (p=0.2320) was found.
Conclusion: Providing opioid education to ED providers was associated with a significant reduction in number of SUs visiting the ED and number of visits made by SUs. Based on average costs of ED visits by SUs, this decrease in visits can be correlated to an estimated savings of over $1 million across five EDs.
背景:每年到急诊科(ED)就诊的数百万成年人都与阿片类药物有关,而那些因慢性疼痛就诊的人更有可能成为急诊科的超级用药者(SUs)。虽然慢性疼痛患者只占总人口的 5%,但他们却占了医疗支出的 50%:方法:美国急诊医学学会(American Academy of Emergency Medicine)的阿片类药物教育项目(American Academy of Emergency Medicine's ACT)将在美国急诊医学学会(American Academy of Emergency Medicine's ACT)的支持下开展:方法:向五家急诊室(估计急诊室年患者总数为 70,000 人)介绍美国急诊医学学会的《急诊室阿片类药物处方指南》。对教育前后一年就诊的 ICD-10 代码进行了疼痛诊断评估,并确定了符合 SU 定义的患者。使用 McNemar 检验和 Z 值对数据进行统计分析:结果:与教育前(304 人)相比,教育后到急诊室就诊一次以上的患者人数有了明显减少(P=0.0006)。接受教育后,SU 患者就诊总次数(268 人次)明显减少(p=0.0017)。非 SU 患者的就诊次数(p=1.9983)和 SU 患者的平均就诊次数(p=0.2320)均无统计学意义上的明显变化:结论:向急诊室医护人员提供阿片类药物教育可显著减少急诊室 SU 患者的就诊人数和 SU 患者的就诊次数。根据急诊室就诊 SU 的平均费用,就诊人数的减少估计可为五家急诊室节省 100 多万美元。